BlumD, HourezR, GalasMC, PopoliP, SchiffmannSN. Adenosine receptors and Huntington's disease: Implications for pathogenesis and therapeutics. Lancet Neurol. 2003; 2:366–374.
4.
NunesEJ, RandallPA, PodurgielS, CorreaM, SalamoneJD. Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: Effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. Neurosci Biobehav Rev. 2013; 37:2015–2025.
5.
FerréS.Mechanisms of the psychostimulant effects of caffeine: Implications for substance use disorders. Psychopharmacology. 2016; 233:1963–1979.
6.
DiasRB, RomboDM, RibeiroJA, HenleyJM, SebastiãoAM. Adenosine: Setting the stage for plasticity. Trends Neurosci. 2013; 36:248–257.
7.
HaskóG, CronsteinBN. Adenosine: An endogenous regulator of innate immunity. Trends Immunol. 2004; 25:33–39.
8.
JulianoLM, FerréS, GriffithsRR. The pharmacology of caffeine. In: The ASAM Principles of Addiction Medicine. RiesR.K.. FiellinD.A., MillerS.C. and SaitzR. (Eds). Philadelphia, PA: Wolters Kluver; 2014: pp. 180–200.
